Treatment of inoperable advanced non-small-cell lung cancer: regimens with or without taxane

Banerjee S, Moher D, Stewart D J
Record ID 32002000923
English, French
Authors' objectives:

This review aims to compare the clinical efficacy of regimens containing taxanes with regimens not containing taxanes, in the treatment of advanced inoperable non-small-cell lung cancer (NSCLC). Outcomes examined include response, survival, toxicity and quality of life (QoL).

Authors' recommendations: Taxane-regimens (TRs) do not significantly improve one-year survival when compared with non-taxane regimens (NTRs) for the treatment of inoperable and advanced NSCLC patients. It should be noted that TRs and NTRs both varied considerably in drug combinations used. TRs showed a greater response rate than NTRs. However, when TRs were compared with NTRs that contained newer chemotherapeutic drugs such as vinorelbine, there was no significant increase in response rate. Treatment regimens typically contain other drugs in addition to a taxane. The companion drug(s) varied from trial to trial, making overall comparison of toxicity difficult. Comparison of impact on QoL between TRs and NTRs was also difficult. Few studies reported QoL data; those that did used different QoL scales. Overall, it appears TRs and NTRs were similar in terms of QoL impact, but a formal analysis was not possible.
Authors' methods: Systematic review
Project Status: Completed
URL for project:
Year Published: 2002
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Antineoplastic Agents
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
Organisation Name: Canadian Coordinating Office for Health Technology Assessment
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553, Fax: +1 613 226 5392;
Contact Name:
Contact Email:
Copyright: Canadian Coordinating Office for Health Technology Assessment (CCOHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.